Gemini price target lowered to $13 from $17 at Truist

Truist lowered the firm’s price target on Gemini (GEMI) to $13 from $17 and keeps a Buy rating on the shares as part of a broader research note previewing Q4 earnings in FinTech. The quarter’s results should be solid, although a tougher y/y comparison may limit volume-related beats, and while Truist is optimistic on the group throughout 2026, some management teams may look to reset Street expectations a bit lower with their original 2026 guidance, the analyst tells investors in a research note.